About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 257 record(s)
Req # A-2020-001606
Adverse Drug Reaction (ADR). Report number: E2B_03343270.Organization: Health Canada
March 2021
Req # A-2020-000946
Information for how many applications have been filed and currently are pending for an Exemption To Use A Controlled Substance. Also how many approvals have been made for exemption of Section 56(1) for sacrament use.Organization: Health Canada
February 2021
Req # A-2019-001278
Adverse Drug Reaction (ADR). Report number: E2B_02541863.Organization: Health Canada
February 2021
Req # A-2020-000382
Adverse Drug Reaction (ADR). Report number: E2B_02755588.Organization: Health Canada
February 2021
Req # A-2020-000438
Adverse Drug Reaction (ADR) for botulinum toxin. Report number: E2B_03073853.Organization: Health Canada
February 2021
Req # A-2020-000660
Adverse Reaction Reports (AERs) for DEXILANT. Report numbers: E2B_03122964, E2B_03123449, E2B_03106078.Organization: Health Canada
February 2021
Req # A-2020-001048
Adverse Reaction Reports (AERs). Report numbers: E2B_02570280, E2B_02570438, E2B_02570510, E2B_02572890, E2B_02573036, E2B_02573068, E2B_02573077, E2B_02573029, E2B_02573078, E2B_02573826.Organization: Health Canada
February 2021
Req # A-2020-001320
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-110687-464, Publication of consumption incidents related to supplemented food, including caffeinated energy drinks.Organization: Health Canada
February 2021
Req # A-2020-001350
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-106853-419, Strategy for and governance of large-scale medical countermeasures including vaccine task force.Organization: Health Canada
February 2021
Req # A-2020-001487
Briefing note and/or briefing materials in the Ministerial Executive Correspondence System (MECS) for the following file: 20-100077-613, Telfer Leading Change Certificate Program.Organization: Health Canada
February 2021